About

Suzy Jackson has spent 15 years at the intersection of pharmaceutical strategy, digital health, and patient-centered care. She is an award-winning executive, widely recognized as a leading voice on commercial strategy in life sciences and digital health.

Suzy learned business excellence at Accenture, rising from Analyst to Managing Director in a decade. She led the North America Life Sciences Commercial Consulting practice, building and running the firm’s response to the industry’s Veeva-Salesforce split, and serving as a trusted advisor to some of the largest pharmaceutical companies in the world on their highest-stakes commercial transformation programs.

She left to become Chief Commercial Officer at RVO Health, the joint venture between UnitedHealth Group and Red Ventures, where she built the company’s B2B digital health division from scratch, designing the commercial model, partnership governance framework, and pharmaceutical pipeline from zero.

Suzy’s unique ability to guide digital health and pharmaceutical services firms lies in her deep, first-hand appreciation of three converging forces: the rise of direct-to-patient offerings and funding across sectors, the emergence of digital health companies as commercial infrastructure for pharmaceutical companies, and the mounting pressure on both sectors to rethink the art of the possible in the age of AI.

Before consulting, Suzy trained as a classical and jazz musician in London, performing across Europe. It’s where she learned that a strong strategy is only as good as the voice behind it. She is also an ICF-certified executive coach, and partners with the leaders she advises to sharpen their voice and presence, on stage, in the boardroom, and in front of investors.

She sits on the boards of Safe Alliance and Equality Now and is deeply passionate about causes surrounding the advancement and protection of women and girls.